Trial Profile
A Study of Safety and Efficacy of Topical Methyl aminolevulinate 80mg/g With and Without Occlusion Followed by Red Light Exposure in Subjects With Facial Acne
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Methyl aminolevulinate (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors PhotoCure
- 01 Sep 2014 New trial record